Diabetes in NAFLD drives high rate of decompensated cirrhosis: Aussie study
Early detection is vital to timely fibrosis risk assessment and treatment to slow disease progression, doctors say.
One in three adults with NAFLD-related cirrhosis and diabetes in the decade up to 2018 progressed to decompensated cirrhosis, an Australian study shows.
Age, hypertension and extrahepatic cancer all influenced the risk of progression, but the hepatologist researchers said diabetes was the most significant factor given its high prevalence.
